019250: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include administration: INTRAVASCULAR, special_features: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 50, primary_container_content_quantity: 50.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-199-8358, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVASCULAR |
| special_features | ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 50 |
| primary_container_content_quantity | 50.000 MILLILITERS |
| NSN | 6505-01-199-8358 |
| ADMINISTRATION | INTRAVASCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 50 |